Life ScienceCompany
MirImmune Ownership
Who owns MirImmune?
MirImmune is owned by Phio Pharmaceuticals. It was acquired on October 12, 2016.
MirImmune Business Overview
Where is MirImmune headquartered?
MirImmune is headquartered in Cambridge, Massachusetts.
What sector is MirImmune in?
MirImmune is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 293 acquisitions of life science companies in 2016, including 32 acquisitions by private equity firms, and 261 by strategics.